# Caidya®: Adapting at The Speed of Science

> Combining expertise with flexible structure, Caidya delivers high\-quality data to support faster, more confident clinical development\.

Generated by Yoast SEO v28.7, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Careers](https://www.caidya.com/careers/)
- [Global Presence](https://www.caidya.com/about/global-presence/)
- [ESG](https://www.caidya.com/about/esg/)
- [About](https://www.caidya.com/about/)
- [Privacy Notices](https://www.caidya.com/privacy-notices/)

## Therapeutics
- [Neurology](https://www.caidya.com/therapeutics/neurology/)
- [Oncology \& Hematology](https://www.caidya.com/therapeutics/oncology-hematology/)
- [Pediatrics](https://www.caidya.com/therapeutics/pediatrics/)
- [Infectious Disease](https://www.caidya.com/therapeutics/infectious-disease/)
- [Immunology](https://www.caidya.com/therapeutics/immunology/)

## Clinical
- [Project Management](https://www.caidya.com/clinical/project-management/)
- [Early Phase Development](https://www.caidya.com/clinical/early-phase-development/)
- [Medical Monitoring](https://www.caidya.com/clinical/medical-monitoring/)
- [Regulatory Services](https://www.caidya.com/clinical/regulatory-services/)
- [Regulatory Strategy](https://www.caidya.com/clinical/regulatory-strategy/)

## Resources
- [Phase I Doesn’t Start in the Clinic, It Starts in Your Strategy](https://www.caidya.com/resources/phase-i-doesnt-start-in-the-clinic-it-starts-in-your-strategy/)
- [Closing the Gaps in Your Clinical Pharmacology Package Before Dossier Submission](https://www.caidya.com/resources/closing-the-gaps-in-your-clinical-pharmacology-package-before-dossier-submission/)
- [Practical Strategies: The Future of Rare Disease Clinical Development](https://www.caidya.com/resources/practical-strategies-the-future-of-rare-disease-clinical-development/)
- [Early Biomarkers as Predictors of Nephrology Trial Trajectory](https://www.caidya.com/resources/early-biomarkers-as-predictors-of-nephrology-trial-trajectory/)
- [Clinical Pharmacology Strategy Accelerates IPF Development ](https://www.caidya.com/resources/case-study-clinical-pharmacology-strategy-accelerates-ipf-development/)

## Blog
- [Beyond the Clinical Endpoint: Why Mental Health Matters in Clinical Research ](https://www.caidya.com/blog/beyond-the-clinical-endpoint-why-mental-health-matters-in-clinical-research/)
- [Caidya Colleague Spotlight: Sarah Gill Steps Forward for the Pink Pear Pootle](https://www.caidya.com/blog/caidya-colleague-spotlight-sarah-gill-steps-forward-for-the-pink-pear-pootle/)
- [\(Blog 8\) Country\-Specific Differences and Local Strategies: Adapting to Europe’s Diverse Landscape](https://www.caidya.com/blog/country-specific-differences-and-local-strategies-adapting-to-europes-diverse-landscape/)
- [\(Blog 7\) Pharmacovigilance and Safety Reporting Requirements for Clinical Trials](https://www.caidya.com/blog/pharmacovigilance-and-safety-reporting-requirements-for-clinical-trials/)
- [\(Blog 6\) IMP Release and Supply Management: Ensuring Compliance from Manufacture to Site](https://www.caidya.com/blog/imp-release-and-supply-management-ensuring-compliance-from-manufacture-to-site/)

## News
- [Caidya Congratulates Partner MediLink on NMPA Acceptance of the New Drug Application for Tam\-Peli \(YL201\)](https://www.caidya.com/news/caidya-congratulates-partner-medilink-on-nmpa-acceptance-of-the-new-drug-application-for-tam-peli-yl201/)
- [Caidya Announces Strategic Combination with Simbec\-Orion Bridging Early Scientific Insight and Global Clinical Execution](https://www.caidya.com/news/caidya-announces-strategic-combination-with-simbec-orion/)
- [CROs dMed and Clinipace merge to accelerate customer success](https://www.caidya.com/news/cros-dmed-and-clinipace-merge-to-accelerate-customer-success/)
- [Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders](https://www.caidya.com/news/caidya-announces-strategic-growth-investment-from-rubicon-founders/)
- [Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion](https://www.caidya.com/news/caidya-names-brandon-pallott-as-cco/)

## Events
- [ESMO Congress 2026](https://www.caidya.com/events/events-esmo-congress-2026/)
- [From Trial Quality to Investor Confidence: The Strategic Value of RBQM and Clinical Data](https://www.caidya.com/events/the-strategic-value-of-rbqm-and-clinical-data-december-2026/)
- [12th BiG IMPACT Conference](https://www.caidya.com/events/event-12th-big-impact-conference/)
- [Outsourcing Clinical Trials \- Nordics](https://www.caidya.com/events/outsourcing-clinical-trials-nordics-2026/)
- [Outsourcing Clinical Trials \- New England](https://www.caidya.com/events/outsourcing-clinical-trials-new-england-2026/)

## Optional
- [Sitemap index](https://www.caidya.com/sitemap_index.xml)